Defence Therapeutics Provides Updates on Sharing Agreement

Montreal, Quebec--(. - September 4, 2026) - Defence Therapeutics Inc. CSE:DTC (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to provide an update on its sharing agreement dated March…